Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Bohn

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The American Journal of Psychiatry|June 1, 2001
Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fractureP S Wang, R L Bohn, R J Glynn, et al.
Archives of Internal Medicine|February 28, 1994
Noncompliance with congestive heart failure therapy in the elderlyM Monane, R L Bohn, J H Gurwitz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 7, 2005
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitorsK G Putnam, R L Bohn, B M Ewenstein, et al.
JAMA|December 13, 1995
Increased incidence of levodopa therapy following metoclopramide useJ Avorn, J H Gurwitz, R L Bohn, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1995
Trends in medication choices for hypertension in the elderly. The decline of the thiazidesM Monane, R J Glynn, J H Gurwitz, et al.
American Journal of Hypertension|July 1, 1997
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderlyM Monane, R L Bohn, J H Gurwitz, et al.
JAMA|September 14, 1994
Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapyJ H Gurwitz, J Avorn, R L Bohn, et al.
Neurology|April 24, 2002
Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated childrenG F A Harding, E L Spencer, J M Wild, et al.
Clinical Pharmacology and Therapeutics|January 1, 1994
Topical glaucoma medications and cardiovascular risk in the elderlyM Monane, R L Bohn, J H Gurwitz, et al.
American Journal of Epidemiology|September 15, 1993
Old age and race as determinants of initiation of glaucoma therapyR J Glynn, J H Gurwitz, R L Bohn, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The American Journal of Psychiatry|June 1, 2001
Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fractureP S Wang, R L Bohn, R J Glynn, et al.
Archives of Internal Medicine|February 28, 1994
Noncompliance with congestive heart failure therapy in the elderlyM Monane, R L Bohn, J H Gurwitz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 7, 2005
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitorsK G Putnam, R L Bohn, B M Ewenstein, et al.
JAMA|December 13, 1995
Increased incidence of levodopa therapy following metoclopramide useJ Avorn, J H Gurwitz, R L Bohn, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1995
Trends in medication choices for hypertension in the elderly. The decline of the thiazidesM Monane, R J Glynn, J H Gurwitz, et al.
American Journal of Hypertension|July 1, 1997
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderlyM Monane, R L Bohn, J H Gurwitz, et al.
JAMA|September 14, 1994
Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapyJ H Gurwitz, J Avorn, R L Bohn, et al.
Neurology|April 24, 2002
Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated childrenG F A Harding, E L Spencer, J M Wild, et al.
Clinical Pharmacology and Therapeutics|January 1, 1994
Topical glaucoma medications and cardiovascular risk in the elderlyM Monane, R L Bohn, J H Gurwitz, et al.
American Journal of Epidemiology|September 15, 1993
Old age and race as determinants of initiation of glaucoma therapyR J Glynn, J H Gurwitz, R L Bohn, et al.
Pageof 4